Recent study also supports that insulin-like growth factor binding protein 5 (IGFBP5) acts as a tumor suppressor in human melanoma by inhibiting EMT phenotype and attenuates the expression of stem cell markers such as Nanog, Sox2, Oct4, KLF4 and CD133 [77]. Here, IGFBP5 is linked to neoplasm.